Clinical trial

Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer

NCT00143390

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-04-01

PhasePHASE3

Study timeline

Study start (unknown)2005-04-01Date precision: month

Registry last updated2012-01-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Neoplasmsunresolved

Interventions

exemestaneDRUG · verified · RxNorm: exemestane

anastrozoleDRUG · verified · RxNorm: anastrozole

Sponsors & collaborators

Pfizerlead sponsor

Mapped research locations

NagoyaAichi-ken, Japan1 SapporoHokkaido, Japan1 YokohamaKanagawa, Japan1 ChibaJapan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00143390 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.